• Molecular NameDutasteride
  • Synonymdutasteride
  • Weight526.565
  • Drugbank_IDDB01126
  • ACS_NO164656-23-9
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)6.55
  • pkaN/A
  • LogD (pH=7, predicted)6.55
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-8.83
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.0
  • No.of HBond Donors2
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds5
  • TPSA41.13
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA 5-alpha-reductase inhibitor, a drug that inhibits the conversion of testosterone into dihydrotestosterone (DHT). It is used to treat conditions caused by DHT, such as benign prostatic hyperplasia (BPH).
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability60.0
  • Protein binding99.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic (CYP3A4-mediated)
  • Half life5 weeks
  • ExcretionFecal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A